Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
08/2003
08/28/2003US20030162768 Treatment of Alzheimer's disease
08/28/2003US20030162721 Anticancer agents; bioavailability; sustained release
08/28/2003US20030162289 Peptides promoting cell adherence, growth and secretion
08/28/2003CA2477159A1 Highly homogeneous molecular markers for electrophoresis
08/28/2003CA2476711A1 Process for preparation of an inhalation powder containing a salt of the cgrp antagonist bibn4096
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/27/2003EP1338605A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres
08/27/2003EP1338604A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
08/27/2003EP1337550A2 Hepatitis c tripeptide inhibitors
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1073672B1 Antipicornaviral compounds, their preparation and use
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003CN1119350C Somatotropin releasing peptide
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119170C Use of micrococcin antibiotics for the preparation of pharmaceuticals for treating or preventing mastitis
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610730 Viricides; protease inbhibitor
08/26/2003US6610722 Inhibitors of prenyl-protein transferase
08/26/2003US6610689 Viricides
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610664 Cationic lipids
08/26/2003US6610658 Modulators of μ-amyloid peptide aggregation
08/26/2003US6610329 Compositions for the delivery of antigens
08/21/2003WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules
08/21/2003WO2003068242A1 Phospholipids as caspase inhibitor prodrugs
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002044324A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
08/21/2003WO2002043773A3 Tissue specific prodrugs
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003US20030158414 Process for preparing growth hormone secretagogues
08/21/2003US20030158380 Immunology diagnosis analyzing; using computer
08/21/2003US20030158248 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide
08/21/2003US20030158236 Treating, e.g., an HIV infection.
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158152 Protease inhibitors and their pharmaceutical uses
08/21/2003US20030158121 Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
08/21/2003US20030158117 Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
08/21/2003US20030158111 Contacting animal's mouth tissue with peptide
08/21/2003US20030157522 Modulate apoptosis; autoimmune diseases, anticancer agents
08/21/2003US20030157487 Nucleic acid ligands
08/21/2003US20030157056 Modified cytokines for use in cancer therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003CA2476292A1 Helical peptidomimetics
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003CN1437442A Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/19/2003US6608204 Peptide aldehyde having arginine or arginine mimics at P1 and pyridone, pyrimidone, or uracil groups; antithrombosis agents
08/19/2003US6608196 Structurally diverse; parallel approach
08/19/2003US6608192 Collections of compounds
08/19/2003US6608175 Oxadiazole, thiadiazoles or triazole metal derivatives reacted with an amine containing aldehyde, deprotecting, coupling with an acid and oxidizing to create substituted oxadiazole, thiadiazole or triazole peptoids
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
08/19/2003US6608030 Inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
08/19/2003US6608027 Macrocyclic peptides active against the hepatitis C virus
08/19/2003CA2111083C Novel peptides, their preparation and use
08/19/2003CA2071674C Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme
08/19/2003CA2070254C Thrombin inhibitors
08/14/2003WO2003066814A2 Peptide-dependent upregulation of telomerase expression
08/14/2003WO2003066673A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003WO2003066672A1 Peptides
08/14/2003WO2003066671A1 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
08/14/2003WO2003066670A2 Dipeptides and tripeptides with anti-inflammatory activity
08/14/2003WO2003066633A1 Novel pyranosyl cytosines: pharmaceutical formulations and methods
08/14/2003WO2003066611A1 Bioluminescent protease assay
08/14/2003WO2003066587A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists
08/14/2003WO2003066068A1 Hpma-polyamine conjugates and uses therefore
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2002064620A3 Metal-binding compounds and uses therefor
08/14/2003WO2001092292A3 Ghrelin analogs
08/14/2003US20030153758 1,3,4-Oxadiazole derivatives and process for producing the same
08/14/2003US20030153727 Controlling protein levels in eucaryotic organisms
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153492 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses
08/14/2003CA2475609A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474695A1 Bioluminescent protease assay
08/14/2003CA2473706A1 Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP0820465B1 Bioprocess for production of dipeptide based compounds
08/13/2003CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/07/2003WO2003064620A2 Hepsin substrates and prodrugs
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064455A2 Macrocyclic peptides active against the hepatitis c virus
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 307